血液透析患者的肺癌手术:多中心十年经验
本研究回顾性分析2007至2016年日本9家机构共39例接受血液透析的肺癌手术患者,评估临床特征、结局及术后并发症危险因素。结果显示总体并发症率30.8%、死亡率7.7%,肺炎最常见,扩大手术与并发症显著相关(P=.04),5年总生存率57.9%,最常见死因为透析相关疾病而非原发性肺癌。
要点
- 血液透析患者肺癌术后并发症率30.8%、死亡率7.7%,肺炎最常见。
- 扩大手术与术后并发症显著相关(P=.04),应权衡治疗获益与侵袭性。
- 5年总生存率57.9%,最常见死因为透析相关疾病而非肺癌。
核心结论
- 血液透析患者肺癌手术长期结局良好,但术后死亡率和并发症率较高。
- 扩大手术与术后并发症显著相关,应个体化选择切除方式。
研究设计与样本
- 回顾性多中心研究,纳入2007至2016年日本9家机构共39例接受血液透析的肺癌手术患者。
主要发现
- 多数患者为男性及吸烟者,糖尿病是原发性肾病最常见原因。
- 16例行肺叶切除加系统淋巴结清扫,6例行扩大手术。
- 69.2%患者为病理IA期肺癌。
- 总体并发症率30.8%,死亡率7.7%,肺炎最常见。
- 扩大手术与并发症显著相关(P=.04),5年总生存率57.9%,最常见死因为透析相关疾病。
关键数值与推荐
- 扩大手术与术后并发症显著相关(P=.04)。
- 总体并发症率30.8%,死亡率7.7%,5年总生存率57.9%。
- 69.2%患者为病理IA期。
临床怎么用
- 对血液透析肺癌患者应充分评估手术风险,谨慎选择切除范围。
- 扩大手术需权衡治疗获益与侵袭性,并关注透析相关疾病管理。
局限性
- 回顾性研究,样本量小(39例),来自单一国家多中心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical outcome of patients undergoing hemodialysis (HD) has not yet been clarified in lung cancer surgery. The aims of this study were to assess the clinical features, outcomes, and main cause of death after lung cancer surgery in patients undergoing HD and to evaluate the risk factors for postoperative complications. METHODS: The study identified 39 patients undergoing HD who had lung cancer surgery in 9 institutions under the Thoracic Surgery Study Group of Osaka University in Japan between 2007 and 2016. Study investigators retrospectively analyzed the surgical outcomes of these patients. RESULTS: Most patients were male and were smokers. Diabetes mellitus was the most common cause of primary renal disease. Lobectomy with systemic lymph node dissection was performed in 16 patients, and an extended operation was performed in 6 patients. Most patients had a diagnosis of pathologic stage IA (69.2%) lung cancer. The overall complication and mortality rates were 30.8% and 7.7%, respectively. Pneumonia was the most frequently observed complication. Extended operation was significantly associated with complications (P = .04). The 5-year overall survival rate was 57.9%, and the most common cause of death was not primary lung cancer but was a disease related to HD. CONCLUSIONS: Lung cancer surgery for patients undergoing HD provides favorable long-term outcomes despite higher postoperative mortality and morbidity rates. Because an extended operation is significantly associated with postoperative complications, thoracic surgeons should carefully select the type of resection on the basis of a balance between therapeutic benefit and invasiveness in these patients.
引用
- Yamamoto Y, Kanzaki R, Ose N, et al. Lung Cancer Surgery for Patients on Hemodialysis: A Decade of Experience at Multicenter Institutions. Ann Thorac Surg. 2020. PMID: 31962110. doi:10.1016/j.athoracsur.2019.11.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。